Pulaski Physical Therapy, Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 3973 Port St, Pulaski, NY 13142 Phone: 315-298-7185 |
Caitlin Taylor Corrice, PT Physical Therapist - Orthopedic Medicare: Accepting Medicare Assignments Practice Location: 61 Delano St, Pulaski, NY 13142 Phone: 315-298-4274 Fax: 315-634-6152 |
Dean Gardner Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 61 Delano St, Pulaski, NY 13142 Phone: 315-298-6564 Fax: 315-298-7488 |
Mr. Christopher Elam Doe, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3973 Port St, Pulaski, NY 13142 Phone: 315-298-5549 |
Scott A Miller, MS PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3973 Port St, Pulaski, NY 13142 Phone: 315-298-7185 |
Anson Dann, PT Physical Therapist - Orthopedic Medicare: Accepting Medicare Assignments Practice Location: 61 Delano St, Pulaski, NY 13142 Phone: 315-298-4274 Fax: 315-634-6152 |
News Archive
The British Columbia Court of Appeals this week is hearing a case to decide whether certain sections of Canada's Controlled Drugs and Substances Act that prevent injection drug users from accessing services at the supervised drug-injection facility Insite in Vancouver, British Columbia, are constitutional, Toronto's Globe and Mail reports (Stueck, Globe and Mail, 4/28).
Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson's disease next week at the Movement Disorders Society Congress in Dublin, Ireland.
A new report in the British Medical Journal indicates that newborns have a lower abundance of entry receptors for SARS-CoV-2.
Results observed from pre-specified interim analyses of the randomized, placebo-controlled Phase 3 study, COU-AA-302, demonstrated that patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (ZYTIGA) plus prednisone showed a statistically significant improvement in radiographic progression-free survival (rPFS) and all secondary endpoints compared to patients treated with placebo plus prednisone.
Even mild depressive symptoms can weaken the outcome of lumbar spinal stenosis surgery, according to a recent study completed at the University of Eastern Finland and Kuopio University Hospital. Patients with depressive symptoms had a weaker functional capacity post-surgery even five years after surgery.
› Verified 2 days ago